Aisling Capital III LP, Ten Percent Owner at Loxo Oncology, holds 2.04M shares in Loxo Oncology (Ticker: LOXO), holds 2.98M shares in Agile Therapeutics (Ticker: AGRX), holds 2.83M shares in T2 Biosystems (Ticker: TTOO). Most recently, Aisling Capital III LP Sold ― shares of Loxo Oncology on Jul 12, 2018 for an estimated value of 251.20M.